News & Analysis on Clinical Trial Services & Contract Research And Development
Danish analytical technology specialist Foss has reported a sharp increase in organic growth in 2004, helped in part by the merger of two of Foss subsidiaries, and the introduction of 10 new products for the world market, reports Wai Lang Chu.
Eriez Magnetics will unveil a new metal detector for pharmaceutical applications at the upcoming Interphex show in New York, US, next month.
India's new patent law, that will prevent domestic pharmaceutical manufacturers from making low-cost generic copies of in-patent drugs - has finally been passed by the lower house of the country's parliament, writes Phil Taylor.
The decreasing number of truly original drugs approved by the Food and Drug Administration is becoming such a serious issue that the pharmaceutical market's tag as the 'innovator industry' is being called into question, reports Wai Lang Chu.
Canadian biopharmaceutical company, Theratechnologies, has announced positive results for its latest drug candidate for the treatment of type II diabetes. The GLP-1 analogue takes its position in the market for this rapidly evolving new class of...
Belgian company Solvay is to buy Fournier Pharma for up to €1.6bn in a move that ties into the group's long-term strategy to boost its activities in the pharmaceuticals sector, reports Phil Taylor.